Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

A method of treating cancer in a HLA-A*02+ patient, wherein said cancer comprises cancer cells that overexpress a LAMC2 polypeptide comprising the amino acid sequence of TLDGAAVNQV (SEQ ID NO:

• 22) and present at their surface in complex with an MHC class I molecule a peptide consisting of the amino acid sequence of TLDGAAVNQV (SEQ ID NO:
• 22), said method comprising administering to said patient an effective amount of activated antigen-specific CD8+ cytotoxic T cells to kill cancer cells, wherein said activated antigen-specific CD8+ cytotoxic T cells are produced by contacting in vitro CD8+ cytotoxic T cells with an antigen presenting cell presenting at its surface in complex with an MHC class I molecule a peptide consisting of the amino acid sequence of TLDGAAVNQV (SEQ ID NO:
• 22), wherein said cancer is selected from pancreatic cancer, esophageal cancer, uterine cancer, gallbladder cancer, and bile duct cancer.